Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06846086 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cardioprotective Effects of Melatonin in Patients With Cardiomyopathy

Study acronym: CEMC
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 26, 2025 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Phase: Phase 1 to Phase 3 Primary endpoints revised (5) · Secondary endpoints: details revised at 2 of 2 entriesv4 Show 2 more changesShow less
    • Primary endpoints revised (5)
    • Secondary endpoints: details revised at 2 of 2 entries

    See this version in full on ClinicalTrials.gov ↗

  2. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1v3 Show 1 more changeShow less
    • Study sites: 0 to 1
  3. Primary endpoints: 4 to 5v2 See this version in full on ClinicalTrials.gov ↗
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of current study is to: Evaluate the cardioprotective effects of melatonin in patients with cardiomyopathy.
Trial Details
NCT Number NCT06846086
Lead Sponsor Tanta University
Conditions Cardiomyopathies
Enrollment 46 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov